TrialCancer immunology research2025

Sintilimab plus Anlotinib in Patients with Pretreated Locally Advanced or Metastatic Sarcoma: A Prospective, Single-Arm, Phase II Clinical Trial.

Heng Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.